Need an oil spill lawyer? We will fight for you!
› $150,000,000 verdict in personal injury case
Lawsuits began last month for four people who say the prescription bowel cleanser OsmoPrep caused them kidney damage that resulted in dialysis. OsmoPrep, made by Salix Pharmaceuticals, is a type of laxative called oral sodium phosphate, or OSP, used to cleanse the intestines prior to procedures such as colonoscopy. Salix Pharmaceuticals began marketing OsmoPrep in 2006. The drug generated more than $30 million in sales in 2008.
One year ago this month, the Food and Drug Administration (FDA) issued a black box warning on a common type of laxative known as oral sodium phosphate, or OSP, available both over-the-counter and by prescription. After years of investigation, the FDA finally alerted health care providers and the public of the risk of a serious kidney injury known as acute phosphate nephropathy associated with the use of OSPs.
The U.S. Preventive Services Task Force, a government-appointed, independent panel of doctors and scientists, raised quite a ruckus with its recommendations on the frequency of mammograms and pap smears, bucking the American Cancer Society’s recommendations by suggesting that fewer screenings were necessary for otherwise healthy women. But the task force’s opinions on colonoscopies mirror those of ACS with at least one small exception – limiting colorectal exams for patients 75 years and older.
Attorney Russell Todd Abney with Beasley Allen Law Firm has filed a lawsuit against C.B. Fleet Company, Inc., on behalf of Mary Little, a resident of Newton County, Georgia, claiming that the plaintiff suffered severe personal injuries as a result of ingesting Fleet’s over-the-counter product known as Fleet Phospho-soda.
A new study presented at the American College of Gastroenterology’s 74th Annual Scientific Meeting in San Diego, Calif., places new emphasis on the importance of adequate bowel preparation prior to colonoscopies. The news comes as clinicians are evaluating new bowel preparation solutions to replace popular ones that were pulled from the market or given a black box warning by the Food and Drug Administration (FDA).
The American Society of Nephrology (ASN), a group that leads the fight against kidney disease in the U.S., holds its annual meeting and scientific exposition next week as part of ASN Renal Week, October 27 – November 1, 2009. The national Renal Week was originally formed as a way to disseminate information on new advances in the science of nephrology. Since then, the educational activities have greatly expanded to meet the needs of both practicing nephrologists and renal scientists.
A study by a group of Italian researchers shows that virtual colonoscopies that use computer tomography scans are almost as effective at detecting tumors and precancerous lesions as standard colonoscopies, which requires threading a camera through the colon. The study, published in The Journal of the American Medical Association, suggests that the new procedure may offer an alternative to people who are too embarrassed or afraid to undergo a standard colonoscopy.
![[ Beasley Allen Law Firm Logo ]](http://www.fleetattorney.net/wp-content/themes/system-unity/images/logo.png){kind=logo}